|
ApoImmune Named a Top Innovator Winner
Award Recognizes Cutting Edge Private Companies Driving the Future of Innovation
Dec. 3, 2009 (Louisville, KY) - ApoImmune, Inc. is pleased to announce that it has been
selected as a winner of the annual New England Venture Summit Top Innovator award by
youngStartup Ventures. The list of privately held companies recognizes those that play a
leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.
As one of the winners, Steven Downey, President & CEO of ApoImmune, will present the
company at the exclusive 2009 New England Venture Summit on December 8th at the Hilton
in Boston Dedham, where a select group of 450 entrepreneurs, investors, and corporate
developers will gather to be the first to meet this next wave of leading edge companies.
ApoImmune is excited and honored to be in this very elite group of youngStartup Ventures Top
finalists.
Honoring the Best
To Honor the youngStartup Ventures Top Innovator recipients, youngStartup Ventures has
invited their CEOs and founders to present at the New England Venture Summit, a forum for the
most exciting early stage and emerging growth companies, and to share their insights on the
future of innovation, and the entrepreneurial journey. Held at the Hilton in Boston Dedham, this
intimate, invitation-only conference is the premier venue for today's promising startups.
About ApoImmune, Inc.
ApoImmune, Inc. is a Louisville, Kentucky-based biotechnology company developing novel
vaccines and immunotherapies, which are treatments based on the concept of regulating the
immune system to fight disease. The Company’s lead vaccine is ApoVax104-HPV, a
therapeutic vaccine for cervical cancer expected to be tested in human clinical trials in Q3 2010. ApoImmune is also developing a second platform technology which improves current
organ and tissue transplant therapies by protecting the transplant from being attacked by the
recipient’s immune system when transplanted into the body.
For more information, visit www.apoimmune.com.
Certain statements made throughout this press release that are not historical facts contain forward-looking statements regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements.
back to Latest News
|
|
|
